Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia
- 15 February 2008
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 75 (4) , 857-865
- https://doi.org/10.1016/j.bcp.2007.10.017
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Nucleoside transporters: from scavengers to novel therapeutic targetsPublished by Elsevier ,2006
- The equilibrative nucleoside transporter family, SLC29Pflügers Archiv - European Journal of Physiology, 2004
- (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside TransportersCurrent Drug Metabolism, 2004
- Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapyOncogene, 2003
- Nucleoside analogues and nucleobases in cancer treatmentThe Lancet Oncology, 2002
- Macrophages require different nucleoside transport systems for proliferation and activationThe FASEB Journal, 2001
- Nucleoside transporters and liver cell growthBiochemistry and Cell Biology, 1998
- Regulation of Nucleoside Transport by Lipopolysaccharide, Phorbol Esters, and Tumor Necrosis Factor-α in Human B-lymphocytesPublished by Elsevier ,1998
- Hormonal regulation of concentrative nucleoside transport in liver parenchymal cellsBiochemical Journal, 1996
- Long term regulation of nucleoside transport by thyroid hormone (T3) in cultured chromaffin cellsNeurochemical Research, 1992